Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("DREGER, P")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 49

  • Page / 2
Export

Selection :

  • and

Evidence that reduction of immunogenicity of T-depleted bone marrow depends on additional depletion of accessory cells : implications for prevention of graft rejectionDREGER, P; MUÊLLER-RUCHHOLTZ, W.Transplantation. 1990, Vol 49, Num 3, pp 622-630, issn 0041-1337, 9 p.Article

Characteristics of relapse after autologous stem-cell transplantation for follicular lymphoma: a long-term follow-upKORNACKER, M; STUMM, J; HO, A. D et al.Annals of oncology. 2009, Vol 20, Num 4, pp 722-728, issn 0923-7534, 7 p.Article

Quantitative MRD monitoring identifies distinct GVL response patterns after allogeneic stem cell transplantation for chronic lymphocytic leukemia : results from the GCLLSG CLL3X trialRITGEN, M; BOTTCHER, S; DÖHNER, H et al.Leukemia. 2008, Vol 22, Num 7, pp 1377-1386, issn 0887-6924, 10 p.Article

Reduced-intensity conditioning prior to allogeneic transplantation of hematopoietic stem cells: the need for T cells early after transplantation to induce a graft-versus-lymphoma effectGLASS, B; NICKELSEN, M; DREGER, P et al.Bone marrow transplantation (Basingstoke). 2004, Vol 34, Num 5, pp 391-397, issn 0268-3369, 7 p.Article

Comparison of different strategies of molecular genetic monitoring following autologous stem cell transplantation in patients with follicular lymphomaVON NEUHOFF, N; DREGER, P; SUTTORP, M et al.Bone marrow transplantation (Basingstoke). 1998, Vol 22, Num 2, pp 161-166, issn 0268-3369Article

Allogeneic peripheral blood progenitor cells for treatment of relapse after bone marrow transplantationGLASS, B; MAJOLINO, I; DREGER, P et al.Bone marrow transplantation (Basingstoke). 1997, Vol 20, Num 7, pp 533-541, issn 0268-3369Article

Sequential high-dose therapy and autologous stem cell transplantation for treatment of mantle cell lymphomaDREGER, P; VON NEUHOFF, N; KUSE, R et al.Annals of oncology. 1997, Vol 8, Num 4, pp 401-403, issn 0923-7534Article

Granulocyte-colony-stimulating factor induces increased serum levels of soluble interleukin 2 receptors preceding engraftment in autologous bone marrow transplantationDREGER, P; GRELE, K; ECKSTEIN, V et al.British journal of haematology. 1993, Vol 83, Num 1, pp 7-13, issn 0007-1048Article

A CD48 monoclonal antibody for reduction of graft immunogenicityDREGER, P; VIEHMANN, K; LOÊFFLER, H et al.Transplantation proceedings. 1990, Vol 22, Num 4, issn 0041-1345, p. 1930Conference Paper

Elevated blood drug levels obtained from indwelling silicon catheters during oral cyclosporine A administrationCLAVIEZ, A; GLASS, B; DREGER, P et al.Bone marrow transplantation (Basingstoke). 2002, Vol 29, Num 6, pp 535-536, issn 0268-3369Article

Outcome and prognostic factors in patients with mantle-cell lymphoma relapsing after autologous stem-cell transplantation: a retrospective study of the European Group for Blood and Marrow Transplantation (EBMT)DIETRICH, S; BOUMENDIL, A; SCHOUTEN, H. C et al.Annals of oncology. 2014, Vol 25, Num 5, pp 1053-1058, issn 0923-7534, 6 p.Article

ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL)GHIELMINI, M; VITOLO, U; STILGENBAUER, S et al.Annals of oncology. 2013, Vol 24, Num 3, pp 561-576, issn 0923-7534, 16 p.Article

Autologous stem-cell transplantation in patients with mantle cell lymphoma beyond 65 years of age: a study from the European Group for Blood and Marrow Transplantation (EBMT)JANTUNEN, E; CANALS, C; LUAN, J. J et al.Annals of oncology. 2012, Vol 23, Num 1, pp 166-171, issn 0923-7534, 6 p.Article

No improvement of survival with reduced- versus high-intensity conditioning for allogeneic stem cell transplants in Ewing tumor patientsTHIEL, U; WAWER, A; YOSHIMI, A et al.Annals of oncology. 2011, Vol 22, Num 7, pp 1614-1621, issn 0923-7534, 8 p.Article

Comparative analysis of minimal residual disease detection using four-color flow cytometry, consensus IgH-PCR, and quantitative IgH PCR in CLL after allogeneic and autologous stem cell transplantationBÖTTCHER, S; RITGEN, M; POTT, C et al.Leukemia. 2004, Vol 18, Num 10, pp 1637-1645, issn 0887-6924, 9 p.Article

Epstein-Barr virus-associated post-transplant lymphoproliferative disease after bone marrow transplantation mimicking graft-versus-host diseaseCLAVIEZ, A; TIEMANN, M; WAGNER, H.-J et al.Pediatric transplantation. 2000, Vol 4, Num 2, pp 151-155, issn 1397-3142Article

Redefining the therapeutic goals in chronic lymphocytic leukemia: Towards an evidence-based, risk-adapted therapyWENDTNER, C. M; SCHMITT, B; WILHELM, M et al.Annals of oncology. 1999, Vol 10, Num 5, pp 505-509, issn 0923-7534Article

Allogeneic peripheral blood progenitor cell transplantation in a murine model : Evidence for an improved graft-versus-leukemia effectGLASS, B; UHAREK, L; ZEIS, M et al.Blood. 1997, Vol 90, Num 4, pp 1694-1700, issn 0006-4971Article

Combined positive/negative selection for highly effective purging of PBPC grafts : towards clinical application in patients with B-CLLPAULUS, U; SCHMITZ, N; VIEHMANN, K et al.Bone marrow transplantation (Basingstoke). 1997, Vol 20, Num 5, pp 415-420, issn 0268-3369Article

Early recurrence or persistence of autoimmune diseases after unmanipulated autologous stem cell transplantationEULER, H. H; MARMONT, A. M; SCHMITZ, N et al.Blood. 1996, Vol 88, Num 9, pp 3621-3625, issn 0006-4971Article

Results of a randomised, controlled, multicentre study of recombinant human granulocyte colony-stimulating factor (filgrastim) in patients with Hodgkin's disease and non-Hodgkin's lymphoma undergoing autologous bone marrow transplantationSCHMITZ, N; DREGER, P; ZANDER, A. R et al.Bone marrow transplantation (Basingstoke). 1995, Vol 15, Num 2, pp 261-266, issn 0268-3369Article

Autologous progenitor cell transplantation : prior exposure to stem cell-toxic drugs determines yield and engraftement of peripheral blood progenitor cell but not of bone marrow graftsDREGER, P; KLÖSS, M; PETERSEN, B et al.Blood. 1995, Vol 86, Num 10, pp 3970-3978, issn 0006-4971Article

Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantationPASSWEG, J. R; BALDOMERO, H; HALTER, J et al.Bone marrow transplantation (Basingstoke). 2014, Vol 49, Num 6, pp 744-750, issn 0268-3369, 7 p.Article

Outcome of patients with HTLV-1-associated adult T-cell leukemia/lymphoma after SCT: a retrospective study by the EBMT LWPBAZARBACHI, A; CWYNARSKI, K; HERMINE, O et al.Bone marrow transplantation (Basingstoke). 2014, Vol 49, Num 10, pp 1266-1268, issn 0268-3369, 3 p.Article

Risk factors and containment of respiratory syncytial virus outbreak in a hematology and transplant unitLEHNERS, N; SCHNITZLER, P; BENNER, A et al.Bone marrow transplantation (Basingstoke). 2013, Vol 48, Num 12, pp 1548-1553, issn 0268-3369, 6 p.Article

  • Page / 2